Oh boy did this week go by fast – for us at least. The past week was filled with earnings from the big guys like Abbott (ABT) and Biogen (BIIB), which often bores us, but if you looked carefully, you’ll see there was still plenty of gossipy gossip circling. Genentech pink slips, The Steet hatin’ on HEB, and Avanir buyout rumors dominated the underground biotech world.

OK, let’s get into it, last week’s Top Ten — the posts that made us all laugh, cry, gasp and say “I saw it first on IguanaBio!!”

10 – The Street: DNDN Went in the Wrong Direction

9 – New Cell Therapeutics Presentation

8 – Pfizer’s Jeff Kindler Speaks: I’m Looking Ahead (take the Pfizer poll)

7 – Not So Fast Denosumab

6 – Rumor: Teva Evaluating Avanir

5 – Did Vatalanib Work for Patrick Swayze?

4 – BREAKING: Roche Starts Axing Genentech Employees, and Its Own

3 – BREAKING: Solvay/Abbott Rumor is True!!! Just for Tricor…

2 – The Street’s Adam Feuerstein Addresses Anti-Semitic Hate Mail

And last week’s #1 post is…

1 – Adam Feuerstein on Hemispherx – WTF???

And that’s the way it is…

Anonymous Tip? Comments? Contact us: hr AT iguanabio DOT com

Related Posts